OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Observational
Safety
Change patient management
15 Publications
found
Implementation of the European Society of Cardiology 0/3-hour accelerated diagnostic protocol, using high sensitive troponin T: a clinical practice evaluation of safety and effectiveness involving 3003 patients with suspected acute coronary syndrome.
b
Open heart
December 26, 2023
p
Cardiovascular Disease
c
Change patient management
Clinical outcomes
Observational
Operational efficiencies
Safety
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
b
Journal of neuro-oncology
September 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Safety
Weight Based Heparin Dosage with Activated Clotting Time Monitoring Leads to Adequate and Safe Anticoagulation in Non-Cardiac Arterial Procedures.
b
Annals of vascular surgery
August 1, 2022
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Observational
Safety
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.
b
BMC medicine
February 1, 2022
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Safety
Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and its influence on patient in-hospital outcome: a retrospective study.
b
Coronary artery disease
September 1, 2021
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Observational
Safety
Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver Disease.
b
The journal of applied laboratory medicine
September 1, 2020
p
Liver Disease
c
Change patient management
Clinical outcomes
Economics
Observational
Patient-centeredness
Safety
Heparin sensitivity and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass.
b
European journal of anaesthesiology
March 1, 2020
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Observational
Safety
Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
b
Journal of managed care & specialty pharmacy
December 1, 2018
p
Pharmacogenetic and Pharmacogenomics
c
Change patient management
Observational
Safety
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
b
The Lancet. Oncology
November 1, 2018
p
Pharmacogenetic and Pharmacogenomics
c
Change patient management
Highlighted
Observational
Safety
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
b
Circulation. Cardiovascular interventions
June 1, 2018
p
ACT Guided Heparinization
c
Change patient management
Clinical outcomes
Highlighted
Observational
Safety
1
2
Next Page
